Penumbra’s Thunderbolt approval poised to accelerate neuro thrombectomy innovation

Penumbra has secured FDA approval for its Thunderbolt system, the first device to offer CAVT for stroke intervention. Thunderbolt is expected to be shipped with Penumbra’s established RED series catheters, pairing familiar catheter designs with the new automated aspiration system. Credit: Piotr Swat via Shutterstock.com. Penumbra has secured FDA approval for its Thunderbolt system, the first device to offer computer-assisted vacuum therapy (CAVT) for stroke intervention. It combines modulated aspiration (automated suction control) with real-time clot detection and enters a market that is already shifting in favour of advanced aspiration technologies. Recent trends point to rapid growth for Penumbra in…

Source: Medical Device Network